Skip to main content

Revance Therapeutics, Inc. - Common Stock (NQ: RVNC )

3.080 UNCHANGED
Streaming Delayed Price Updated: 1:00 PM EST, Dec 24, 2024 Add to My Watchlist

Other Filings

Form DEF 14A
Source: SEC/Edgar
March 24, 2019
Form CT ORDER
Source: SEC/Edgar
March 17, 2019
Form 8-K
Source: SEC/Edgar
March 14, 2019
Form S-8
Source: SEC/Edgar
February 27, 2019
Form 8-K
Source: SEC/Edgar
February 25, 2019
Form SC 13G
Source: SEC/Edgar
February 13, 2019
Form SC 13G/A
Source: SEC/Edgar
February 12, 2019
Form SC 13G/A
Source: SEC/Edgar
February 11, 2019
Form SC 13G/A
Source: SEC/Edgar
February 11, 2019
Form SC 13G/A
Source: SEC/Edgar
February 05, 2019
Form SC 13G/A
Source: SEC/Edgar
January 28, 2019
Form SC 13G/A
Source: SEC/Edgar
January 27, 2019
Form 8-K
Source: SEC/Edgar
January 24, 2019
Form 424B5
Source: SEC/Edgar
January 16, 2019
Form 8-K
Source: SEC/Edgar
January 16, 2019
Form 424B5
Source: SEC/Edgar
January 14, 2019
Form 8-K
Source: SEC/Edgar
January 14, 2019
Form SC 13G/A
Source: SEC/Edgar
January 03, 2019
Form 8-K
Source: SEC/Edgar
December 03, 2018
Form 8-K
Source: SEC/Edgar
October 31, 2018
Form 8-K
Source: SEC/Edgar
October 10, 2018
Form CT ORDER
Source: SEC/Edgar
September 05, 2018
Form 8-K
Source: SEC/Edgar
August 01, 2018
Form 8-K
Source: SEC/Edgar
June 21, 2018
Form CT ORDER
Source: SEC/Edgar
June 10, 2018
Form 8-K
Source: SEC/Edgar
May 28, 2018
Form 8-K
Source: SEC/Edgar
May 10, 2018
Form 8-K
Source: SEC/Edgar
May 07, 2018
Form 8-K
Source: SEC/Edgar
April 18, 2018
Form SC 13G/A
Source: SEC/Edgar
April 09, 2018
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.